Growth N. V. Biotech, 10% Owner at Black Diamond Therapeutics, Inc. (BDTX), bought 1,740,000 shares at $5.49 ($9.6M) on 2023-06-27, disclosed to the SEC on 2023-06-29.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| Filing → |
| BDTX | BUY | 2022-11-02 | $449K | — | Filing → |
| EPIX | BUY | 2022-10-28 | $8.2M | — | Filing → |
| EPIX | BUY | 2022-07-18 | $3.5M | — | Filing → |